These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 728214)

  • 21. Hypolipidemic action of a new aryloxy compound (S-8527) in rats.
    Toki K; Nakamura Y; Agatsuma K; Nakatani H; Aono S
    Atherosclerosis; 1973; 18(1):101-8. PubMed ID: 4741527
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic effects of clofibrate on experimental animals.
    Bedö M; Kramer M; Blaskovits A; Gefferth G; Tarjan R
    Arzneimittelforschung; 1978; 28(7):1076-80. PubMed ID: 582692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of clofibrate on the handling of dietary and liver fat.
    Westerfeld WW; Elwood JC; Richert DA
    Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interactive effect of dietary glycerol and corn oil on rat liver lipids, serum lipids and serum lipoproteins.
    Narayan KA; McMullen JJ
    J Nutr; 1979 Nov; 109(11):1836-46. PubMed ID: 501436
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 27. Sex-steroids and hypolipidemic chemicals impacts on brown trout lipid and peroxisome signaling - Molecular, biochemical and morphological insights.
    Madureira TV; Malhão F; Simões T; Pinheiro I; Lopes C; Gonçalves JF; Urbatzka R; Castro LFC; Lemos MFL; Rocha E
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Oct; 212():1-17. PubMed ID: 29885532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased conversion ratio of tryptophan to niacin by the administration of clofibrate, a hypolipidemic drug, to rats.
    Shibata K; Kondo T; Marugami M; Umezawa C
    Biosci Biotechnol Biochem; 1996 Sep; 60(9):1455-9. PubMed ID: 8987594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and prevention of fatty liver in rats fed clofibrate and orotic acid diets containing sucrose.
    Novikoff PM; Roheim PS; Novikoff AB; Edelstein D
    Lab Invest; 1974 Jun; 30(6):732-50. PubMed ID: 4835600
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
    Muroya Y; Ito O
    Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of peroxisomes in lipid metabolism in animal cells; fibrates (hypolipidemic drugs)-caused alterations in lipid metabolism].
    Kawashima Y
    Tanpakushitsu Kakusan Koso; 1993 Apr; 38(5):843-56. PubMed ID: 8516444
    [No Abstract]   [Full Text] [Related]  

  • 34. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tannic acid is more effective than clofibrate for the elevation of hepatic β-oxidation and the inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase and aortic lesion formation in apo E-deficient mice.
    Do GM; Kwon EY; Ha TY; Park YB; Kim HJ; Jeon SM; Lee MK; Choi MS
    Br J Nutr; 2011 Dec; 106(12):1855-63. PubMed ID: 21736774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
    Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
    Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental research on the action of a derivative from a p-chloropenoxyisobutyric acid series on lipid parameters].
    Filip M; Hriscu A; Păduraru I; Rusu M
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):156-60. PubMed ID: 3764166
    [No Abstract]   [Full Text] [Related]  

  • 38. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
    Seri K; Matsuo T; Asano M; Sato R; Kato T
    Arzneimittelforschung; 1978; 28(10):1711-2. PubMed ID: 582674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mitochondrial tricarboxylate anion translocation and of liver fatty acid synthesis by a new hypolipidemic agent.
    Ribereau-Gayon G
    FEBS Lett; 1976 Mar; 62(3):309-12. PubMed ID: 1278374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.